InhaleRx Limited (IRX.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.57 Million AUD | -30.17% |
| 2022 | 2.25 Million AUD | -22.96% |
| 2021 | 2.93 Million AUD | 53.95% |
| 2020 | 1.9 Million AUD | 205.27% |
| 2019 | 623.71 Thousand AUD | -79.82% |
| 2018 | 3.09 Million AUD | -39.23% |
| 2017 | 5.08 Million AUD | -40.69% |
| 2016 | 8.57 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 581.75 Thousand AUD | -63.11% |
| 2024 Q2 | 581.75 Thousand AUD | 0.0% |
| 2023 FY | 1.57 Million AUD | -30.17% |
| 2023 Q1 | 1.12 Million AUD | -50.39% |
| 2023 Q2 | 1.12 Million AUD | 0.0% |
| 2023 Q3 | 1.57 Million AUD | 40.77% |
| 2023 Q4 | 1.57 Million AUD | 0.0% |
| 2022 Q4 | 2.25 Million AUD | 0.0% |
| 2022 Q2 | 2.08 Million AUD | 0.0% |
| 2022 FY | 2.25 Million AUD | -22.96% |
| 2022 Q1 | 2.08 Million AUD | -28.87% |
| 2022 Q3 | 2.25 Million AUD | 8.31% |
| 2021 Q1 | 3.65 Million AUD | 83.14% |
| 2021 FY | 2.93 Million AUD | 53.95% |
| 2021 Q3 | 2.93 Million AUD | -19.75% |
| 2021 Q2 | 3.65 Million AUD | 0.0% |
| 2021 Q4 | 2.93 Million AUD | 0.0% |
| 2020 Q3 | 1.9 Million AUD | 166.75% |
| 2020 FY | 1.9 Million AUD | 205.27% |
| 2020 Q4 | 1.99 Million AUD | 4.75% |
| 2020 Q2 | 713.79 Thousand AUD | 0.0% |
| 2020 Q1 | 713.79 Thousand AUD | 14.44% |
| 2019 Q2 | 2.02 Million AUD | 0.0% |
| 2019 Q1 | 2.02 Million AUD | -34.59% |
| 2019 FY | 623.71 Thousand AUD | -79.82% |
| 2019 Q4 | 623.71 Thousand AUD | 0.0% |
| 2019 Q3 | 623.71 Thousand AUD | -69.15% |
| 2018 Q3 | 3.09 Million AUD | -19.86% |
| 2018 Q1 | 3.85 Million AUD | -24.17% |
| 2018 FY | 3.09 Million AUD | -39.23% |
| 2018 Q4 | 3.09 Million AUD | 0.0% |
| 2018 Q2 | 3.85 Million AUD | 0.0% |
| 2017 Q1 | 6.35 Million AUD | 0.0% |
| 2017 Q4 | 5.08 Million AUD | 0.0% |
| 2017 FY | 5.08 Million AUD | -40.69% |
| 2017 Q2 | 6.35 Million AUD | 0.0% |
| 2017 Q3 | 5.08 Million AUD | -19.95% |
| 2016 Q2 | 351.55 Thousand AUD | 0.0% |
| 2016 FY | 8.57 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| 4DMedical Limited | 120.01 Million AUD | 98.686% |
| Adherium Limited | 9.88 Million AUD | 84.051% |
| Aroa Biosurgery Limited | 101.82 Million AUD | 98.451% |
| Atomo Diagnostics Limited | 11.37 Million AUD | 86.142% |
| Anteris Technologies Ltd | 45.7 Million AUD | 96.55% |
| Control Bionics Limited | 9.02 Million AUD | 82.532% |
| CardieX Limited | 12.64 Million AUD | 87.534% |
| Compumedics Limited | 40.35 Million AUD | 96.093% |
| Cochlear Limited | 2.74 Billion AUD | 99.943% |
| CleanSpace Holdings Limited | 26.05 Million AUD | 93.947% |
| Cyclopharm Limited | 45.91 Million AUD | 96.566% |
| EMVision Medical Devices Ltd | 23.97 Million AUD | 93.422% |
| Nova Eye Medical Limited | 29.88 Million AUD | 94.723% |
| HeraMED Limited | 2.95 Million AUD | 46.584% |
| Imricor Medical Systems, Inc. | 12.17 Million AUD | 87.049% |
| ImpediMed Limited | 46.98 Million AUD | 96.644% |
| LBT Innovations Limited | 7.93 Million AUD | 80.117% |
| Micro-X Limited | 26.89 Million AUD | 94.137% |
| Neurotech International Limited | 12.21 Million AUD | 87.089% |
| OncoSil Medical Limited | 6.71 Million AUD | 76.529% |
| PolyNovo Limited | 109.16 Million AUD | 98.556% |
| Respiri Limited | 6.19 Million AUD | 74.529% |
| SomnoMed Limited | 69.8 Million AUD | 97.741% |
| Universal Biosensors, Inc. | 30.12 Million AUD | 94.765% |
| Uscom Limited | 5.13 Million AUD | 69.289% |
| Visioneering Technologies, Inc. | 11.2 Million AUD | 85.927% |